norethindrone has been researched along with Menopause in 228 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 154 (67.54) | 18.7374 |
1990's | 41 (17.98) | 18.2507 |
2000's | 27 (11.84) | 29.6817 |
2010's | 6 (2.63) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Granqvist, CJ; Ipsen, HE; Kokot-Kierepa, M; Mattsson, LÅ | 1 |
Pertyńska-Marczewska, M; Pertyński, T; Stachowiak, G | 1 |
Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A | 1 |
Johansen, OE; Qvigstad, E | 1 |
de Carvalho, MN; Dos Reis, RM; Ferriani, RA; Mendes, MC; Nobre, F; Silva de Sá, MF | 1 |
Angelova, M; Monastirska, M; Tsvetkov, K | 1 |
Fournier, A; Weiderpass, E | 1 |
Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C | 1 |
Beksinska, ME; Farley, TM; Kleinschmidt, I; Smit, JA | 1 |
Borowiecka, M; Nowak, P; Połać, I; Wilamowska, A | 1 |
Jamin, C; Madelenat, P; Poncelet, C | 1 |
Keil, D; Lang, E; von Holst, T; Winkler, U | 1 |
Benussi, C; Bevilacqua, G; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Monteleone, P | 1 |
Coyle, D; Cranney, A; Tugwell, P | 1 |
Arabi, A; Benhamou, CL; Garnero, P; Pelissier, C; Porcher, R; Roux, C | 1 |
APPLEBY, B | 1 |
FLOWERS, C; GARCIA, CR; GOLDFARB, AF; TYLER, ET | 1 |
BORY, R; CAPLIER, P | 1 |
RINGROSE, CA | 1 |
CAMERON, WJ; WARREN, JC | 1 |
BURT, RK | 1 |
OEYEN, R; PEETERS, F; VANROY, M | 1 |
ANDREWS, JT; MOTTERAM, R; STOLL, BA; UPFILL, J | 1 |
CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
LITTLE, V; SWYER, GI | 1 |
Calaf, J; Cano, A; Molina, J | 1 |
Beksinska, ME; Farley, TM; Guidozzi, F; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
Crawford, L; Gallacher, S; Greer, IA; Jaap, AJ; Kelly, A; Lowe, GD; McKenzie, J; Paterson, K; Petrie, JR; Rumley, A; Sattar, N | 1 |
Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studard, E | 1 |
Bäckström, T; Bixo, M; Jonsson, B; Odmark, IS | 1 |
Dalsgaard, T; Lund, CO; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 1 |
Adaro, L; Albrecht, G; Baracat, EC; Bassol, S; Bayo, J; Blanco, S; Boccanera, R; Camargos, AF; Carranza-Lira, S; Celis-Gonzalez, C; da Fonseca, AM; da Sá, MF; de la Loza, FR; Gomez, G; Gurucharri, C; Llaca, V; Martinez, N; Murga, M; Murillo, A; Naranjo, C; Reyes-Marquez, R; Rios, PC; Sanchez, F; Santos, J; Santoyo, S; Sayegh, F; Siseles, N; Tempone, A; Tempone, LM; Tozzini, RI; Zarain, J | 1 |
Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL | 1 |
Azavedo, E; Carlström, K; Hofling, M; Kloosterboer, H; Svane, G; Von Schoultz, B | 1 |
Fisher, BM; Jaap, AJ; McKenzie, J; Paterson, K; Sattar, N; Stanley, A | 1 |
Eren, S; Kutlu, T; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
Archer, DF; Gut, R; Lang, E; Panay, N; Ylikorkala, O | 1 |
Bonassi Machado, R; Chada Baracat, E; Eduardo Fernandes, C; Marcelo Lakryc, E; Rodrigues De Lima, G | 1 |
Rizkallah, TH; Taymor, ML | 1 |
Dudley, B | 1 |
Albrechtsen, OK; Astrup, T; Brakman, P | 1 |
Cameron, EH; Dean, PD; Lind, T; Morgan, MR; Whittaker, PG | 1 |
Morsman, J; Varma, TR | 1 |
Varma, TR | 2 |
Moore, B; Paterson, ME; Sturdee, DW; Whitehead, TP | 3 |
King, RJ; Townsend, PT; Whitehead, MI | 1 |
King, RJ; Lane, G; Pryse-Davies, J; Ryder, T; Siddle, N; Townsend, PT; Whitehead, MI | 1 |
King, RJ; Minardi, J; Siddle, NC; Townsend, PT; Whitehead, MI; Young, O | 1 |
Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
Christiansen, C; Gotfredsen, A; Transbøl, I | 1 |
Christiansen, C; Riis, BJ | 2 |
Christiansen, C; Rødbro, P; Tjellesen, L | 1 |
Gordan, GS | 1 |
Brincat, M; Cooper, D; Darby, AJ; Magos, A; Moniz, CF; Studd, JW | 1 |
Hellberg, D; Nilsson, S | 1 |
Carlström, K; Furuhjelm, M; Karlgren, E | 1 |
Catherwood, BD; Christiansen, C; Deftos, LJ; Pødenphant, J | 1 |
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J | 1 |
Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F | 1 |
Cullberg, G; Mattsson, LA; Samsioe, G | 1 |
Evans, DV; Nordin, BE; Smith, M; Vella, PV | 1 |
Farish, E; Fletcher, CD; Hart, DM; Kitchener, H; Sharpe, GL | 1 |
Clark, DM; Farish, E; Fletcher, CD; Hart, DM; Kitchener, H; Leggate, J; Sharpe, GL | 1 |
Christiansen, C; Rødbro, P | 2 |
Abrahamsson, L; Cullberg, G; Mattsson, LA; Samsioe, G | 1 |
Davies, TC; Hahn, RG; Nachtigall, RD | 1 |
Christensen, MS; Christiansen, C; Grande, P; Transbøl, I | 1 |
Christensen, MS; Christiansen, C; Hagen, C; Transbøl, I | 2 |
Lähteenmäki, P; Sipinen, S | 1 |
Christensen, MS; Christiansen, C; Hagen, C; Rødbro, P; Transbøl, I | 1 |
Sheehan, JP | 1 |
Christensen, MS; Christiansen, C; Hagen, C; Stocklund, KE; Transbøl, I | 2 |
Craft, IL; Mugglestone, CJ; Swinhoe, JR | 1 |
Brøns, M; Jacobsen, JG; Kristoffersen, K | 1 |
Staland, B | 2 |
Christiansen, C; Jensen, GF; Transbøl, I | 1 |
Roberts, JM | 1 |
Allen, J; Jordan, JA; Paterson, ME | 1 |
King, RJ; Lane, G; Pryse-Davies, J; Ryder, T; Siddle, NC; Townsend, PT; Whitehead, MI | 1 |
Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 1 |
Collins, A; Eneroth, P; Frankenhaeuser, M; Hagenfeldt, K; Hanson, U; Lundberg, U | 1 |
Collins, WP; Dyer, G; King, RJ; Lane, G; Townsend, PT; Whitehead, MI | 1 |
Müller, G | 1 |
Christensen, MS; Christiansen, C; Hagen, C; Jensen, J; Stocklund, KE; Transbøl, I | 1 |
King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI | 1 |
Crilly, RG; Horsman, A; Marshall, DH; Nordin, BE; Simpson, M | 1 |
Hirvonen, E; Mälkönen, M; Manninen, V | 1 |
Frenkel, Y; Kopernik, G; Lazer, S; Oettinger, M; Serr, DM; Tendler, R; Tugendreich, D; Zmira, N | 1 |
Crawford, FE; Grudzinskas, JG; Jenkins, AW; Norman-Taylor, JQ | 1 |
Bankowska, UZ; Capell, HA; MacDonald, AG; Murphy, EA; Ralston, SH | 1 |
Fraser, D; Pryse-Davies, J; Schenkel, L; Whitehead, M | 1 |
Crook, D; Godsland, IF; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
DeCherney, A | 1 |
Abrams, K; al-Azzawi, F; Bell, SC; Habiba, MA | 1 |
Christensen, A; Damber, MG; Hirvonen, E; Milsom, I; Saure, A | 1 |
Dal Magro, L; Dal Pozzo, M; Ferroni, E; Maggino, T; Marchesoni, D; Mozzanega, B; Paternoster, DM; Romagnolo, C | 1 |
Chung, TK; Haines, CJ; Lau, TK | 1 |
Stadberg, E | 1 |
Aoki, T; Fukatsu, T; Kaba, S | 1 |
Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T | 1 |
Hermann, AP; Mosekilde, L; Orskov, H; Vestergaard, P | 1 |
Andersson, K; Karlsson, K; Lagrelius, A; Lindgren, R; Mattsson, LA; Risberg, B; Sandin, K | 1 |
Archer, DF; Dain, MP; Furst, K; Tipping, D; Vandepol, C | 1 |
De Jong, SA; Edwards, EA; Lewis-Barned, NJ; Markham, VH; Sutherland, WH; Walker, HL; Walker, RJ | 1 |
Cassel, D; Dain, MP; Furst, KW; Hille, D; Notelovitz, M; Skarinsky, D; VandePol, C | 1 |
Clapp, JF; Kamali, P; Lang, U; Müller, T | 1 |
Gloudemans, RH; Groothuis, GM; Rietjens, IM; Verhoeven, CH; Vos, RM | 1 |
Arce, JC; Baerug, U; Faber-Swensson, E; Heldaas, K; Larsen, S; Nordland, G; Norling, B; Winge, T | 1 |
Alexandersen, P; Bjarnason, NH; Christiansen, C | 1 |
Cohen, SB; Lidor, AL; Lipitz, S; Mashiach, S; Novikov, I; Rabinovici, J; Seidman, DS | 1 |
Paterson, ME; Studd, JW; Sturdee, DW; Thom, MH; Wade-Evans, T; White, PJ; Williams, RM | 1 |
Stryker, JC | 1 |
Chakravarti, S; Oram, DH; Studd, JW; Thom, M | 1 |
Davajan, V; Kawagoe, S; Mishell, DR; Moore, DE; Nakamura, RM | 1 |
Campbell, S; King, RJ; Minardi, J; Whitehead, MI | 1 |
Beard, RJ; Campbell, S; McQueen, J; Minardi, J; Whitehead, MI | 1 |
Gallagher, JC; Guha, P; Hanes, F; Marshall, DH; Nordin, BE; Oldfield, W | 1 |
Adlercreutz, H; Lillienberg, L; Svanborg, A | 1 |
Di Pietro, S; Mauri, M; Tancini, G; Varini, M | 1 |
Damber, MG; Sandström, B; Stigbrand, T; von Schoultz, B | 1 |
Carlström, K; Furuhjelm, M | 1 |
Craft, I; Mugglestone, CJ; Swinhoe, J | 1 |
Knoth, M; Nathan, E; Nilsson, BO | 1 |
Dalén, N; Furuhjelm, M; Jacobson, B; Lamke, B | 1 |
Maddock, J | 1 |
Bradwell, AR; Burnett, D; Moore, B; Sturdee, DW | 1 |
Bradwell, AR; Burnett, D; Moore, B; Studd, JW; Williams, JG | 1 |
Magnani, HN; Moore, B | 1 |
Borglin, NE; Staland, B | 1 |
Jones, GS; Rocco, L; Wentz, AC | 1 |
Borg, V; Chretien, FC; Cohen, J; Psychoyos, A | 1 |
Diamant, YZ; Kleinman, Y; Livshin, Y; Reisin, A; Tadmor, OP | 1 |
Diamant, YZ; Goldstein, R; Kleinman, Y; Tadmor, OP | 1 |
Pouilles, JM; Ribot, C; Tremollieres, F | 1 |
Berg, G; Hammar, M; Karlberg, J; Lindgren, R; Sandin, K; Wiklund, I | 1 |
Leather, AT; Savvas, M; Studd, JW | 1 |
Christiansen, C; Marslew, U; Riis, BJ | 1 |
Barnes, JF; Farish, E; Hart, DM; Rolton, HA | 1 |
LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
Bŭrdarova, I; Katsarova, M; Rachev, E | 1 |
Crook, D; Fraser, D; Schenkel, L; Stevenson, JC; Whitehead, MI | 1 |
Bourne, T; Campbell, S; Crook, D; Hillard, TC; Whitehead, MI | 1 |
Cust, MP; Gangar, KF; Hillard, TC; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
Stones, RW | 1 |
Björntorp, P; Crona, N; Lindberg, UB; Rebuffé-Scrive, M; Silfverstolpe, G | 1 |
Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
Christiansen, C; Hartwell, D; Riis, BJ | 1 |
Christiansen, C; Jensen, SB; Johansen, JS; Riis, BJ | 1 |
Christiansen, C; Hassager, C; Jensen, LT; Pødenphant, J; Riis, BJ | 1 |
Byrjalsen, I; Christiansen, C; Riis, BJ | 2 |
Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Ross, MS | 1 |
Chatterton, B; Horowitz, M; Need, A; Nordin, BE; Wishart, J | 1 |
Fraser, DI; Parsons, A; Pryse-Davies, J; Stuart, G; Whitehead, MI; Wordsworth, J | 1 |
Asai, M; Masahashi, T; Narita, O; Ohsawa, M; Wu, MC | 1 |
Chase, JS; Check, JH; Spence, M | 1 |
Kanka, J; Mensík, J; Pacovský, V; Pospíchal, J; Presl, J; Schreiber, V; Stĕpán, JJ | 1 |
Dramusic, V; Goh, HH; McCarthy, TG; Ratnam, SS | 1 |
Doi, M; Furuya, K; Ikemoto, Y; Kawano, T; Koshikawa, N; Seki, K; Somemura, K; Tatsunuma, T | 1 |
Christiansen, C; Jensen, J; Riis, BJ; Strøm, V | 2 |
Larsen, S; Mattsson, LA; Samsioe, G; Sporrong, T | 1 |
Gürtler, R; Schmidt, UM; Stier, G | 1 |
Hellgren, M; Mattsson, LA; Samsioe, G; Sporrong, T | 1 |
Al-Azzawi, F; Dagen, MM; Farish, E; Fletcher, CD; Hart, DM; Howie, CA; Parkin, DE | 1 |
Rachev, E | 1 |
Endacott, J; Fraser, D; Morton, J; Pryse-Davies, J; Ryder, TA; Whitehead, MI | 1 |
Christiansen, C; Deftos, L; Nilas, L; Riis, BJ; Rødbro, P | 1 |
Fotherby, K | 1 |
King, RJ; Whitehead, MI | 1 |
Dechaud, H; Fleury, MC; Lejeune, H; Mazenod, B; Pugeat, M; Tourniaire, J | 1 |
Brincat, M; Magos, AL; O'Dowd, T; Schlesinger, P; Studd, JW; Wardle, P | 1 |
Alessandrini, G; Comitini, G; D'Ambrogio, G; Facchinetti, F; Genazzani, AR; Petraglia, F; Volpe, A | 1 |
Fribourg, S | 1 |
Campanini, D; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A | 1 |
Abdalla, HI; Beastall, G; Fletcher, D; Hart, DM; Hawthorn, JS; Smith, J | 1 |
Christiansen, C; Johansen, J; Riis, BJ | 1 |
Bennett, P; Fink, B; Micic, S; Moller, S; Svenstrup, B | 1 |
Lobo, RA | 1 |
Fraser, D; Whitehead, MI | 1 |
Christiansen, C; Jensen, J | 1 |
Frenchek, B; Gordon, EM; Mazur, CA; Speroff, L; Williams, SR | 1 |
Dagen, M; Deeny, M; Farish, E; Fletcher, CD; Hart, DM; Tillman, J | 1 |
Gambrell, RD | 2 |
Christiansen, C; Larsen, NE; Pødenphant, J; Riis, BJ | 1 |
Loikkanen, M; Luotola, H; Pyörälä, T | 1 |
Francis, RM; Selby, PL | 1 |
Christiansen, C; Jensen, J; Nilas, L | 1 |
Peacock, M; Selby, PL | 1 |
Dagen, MM; Farish, E; Fletcher, CD; Hart, DM; Parkin, DE | 1 |
Brewster, E; Brincat, M; Magos, AL; O'Dowd, T; Singh, R; Studd, JW | 1 |
Assa, S; Bacalu, B; Blum, I; Blum, M; Honig, B | 1 |
Horowitz, M; Morris, H; Need, AG; Nordin, BE; Philcox, J; Wishart, J | 1 |
Mattsson, LA; Samsioe, G | 1 |
Christiansen, C | 1 |
Barkworth, SA; Brown, WB; Peacock, M; Selby, PL; Taylor, GA | 1 |
Endacott, J; Padwick, ML; Pryse-Davies, J; Whitehead, MI | 1 |
Christiansen, C; Jensen, J; Rødbro, P | 1 |
Frenkel, Y; Goldwasser, B; Menczer, J; Rabinovici, J; Serr, DM | 1 |
Chilvers, DC; Dawson, JB; Hodgkinson, A; Jones, MM; Selby, PL | 1 |
Abdalla, HI; Hart, DM; Hooke, A; Leggate, I; Lindsay, R | 1 |
Brincat, M; Magos, AL; O'Dowd, T; Schlesinger, P; Studd, JW; Wardle, PJ | 1 |
Vikhliaeva, EM | 1 |
Tamaoka, T | 1 |
Boon, RC; Parlow, AF; Reichlin, S; Schalch, DS | 1 |
Zussman, L | 1 |
Molitch, ME; Odell, WD; Oill, P | 1 |
Lachnit, U; Warnecke, G | 1 |
Dargent, M; Pommatau, E; Servonnat, F | 1 |
Burnier, AM; Huix, FJ; Martin, PL; Segre, EJ | 1 |
Burnier, AM; Greaney, MO; Martin, PL | 1 |
Abdel-Daim, MH; Abdel-Tawab, GA; Girgis, LH; Kelada, NL; Moursi, GE | 1 |
Ayalon, D; Cession, G; Franchimont, P; Legros, JJ; Mutsers, A | 1 |
Leyendecker, G; Saxena, BB | 1 |
Franchimont, P | 1 |
Cope, E | 1 |
10 review(s) available for norethindrone and Menopause
Article | Year |
---|---|
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Topics: Antidepressive Agents; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Humans; Menopause; Norethindrone; Norethindrone Acetate | 2008 |
[Tibolone].
Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors | 2002 |
[GYNECOLOGY].
Topics: Abortion, Threatened; Ascites; Capillary Resistance; Endometriosis; Estriol; Estrogens; Female; Genital Neoplasms, Female; Glycoside Hydrolases; Gold Isotopes; Gonadal Steroid Hormones; Gonadotropins; Gynecology; Humans; Menopause; Neoplasms; Norethindrone; Norethynodrel; Ovarian Neoplasms; Polycystic Ovary Syndrome; Pregnancy; Pregnanediol; Progesterone; Progestins; Uterine Prolapse | 1963 |
Prevention of bone loss and fractures in women.
Topics: Age Factors; Aged; Bone and Bones; Calcium; Estrogens; Female; Fractures, Spontaneous; Humans; Menopause; Middle Aged; Norethindrone; Organ Size; Osteoporosis; Phosphorus; Racial Groups; Sex Factors; Uterine Neoplasms | 1984 |
Oestrogens and hypertension.
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiac Output; Cardiovascular Diseases; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pituitary-Adrenal System; Progestins; Prospective Studies; Prostaglandins; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1981 |
Bone-sparing properties of oral contraceptives.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone; Osteoporosis, Postmenopausal; Premenopause | 1996 |
Absorption and metabolic effects of different types of estrogens and progestogens.
Topics: Absorption; Administration, Oral; Estradiol Congeners; Estrogens; Female; Humans; Intestinal Absorption; Menopause; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1987 |
The effects of estrogens and progestogens on the endometrium. Modern approach to treatment.
Topics: Drug Administration Schedule; Endometrium; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage; Uterine Neoplasms | 1987 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
[New achievements in gynecology].
Topics: Contraceptives, Oral; Culdoscopy; Estrogens; Female; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Infertility, Female; Laparoscopy; Menopause; Menstruation; Menstruation Disturbances; Norethindrone; Ovary; Progesterone; Transplantation, Homologous | 1974 |
76 trial(s) available for norethindrone and Menopause
Article | Year |
---|---|
[Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women].
Topics: Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Treatment Outcome | 2008 |
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners | 2010 |
Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
Topics: Administration, Oral; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Menopause; Middle Aged; Norethindrone; Poland; Postmenopause; Progestins; Risk Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
Topics: Adult; Aged; Austria; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Germany; Hot Flashes; Humans; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2002 |
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.
Topics: Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2003 |
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study.
Topics: Adipose Tissue; Alkaline Phosphatase; Body Composition; Bone and Bones; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteocalcin; Peptides; Prospective Studies; Thinness | 2003 |
The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
Topics: Administration, Cutaneous; Cholesterol; Cholesterol, LDL; Climacteric; Estradiol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Prospective Studies; Spain; Triglycerides | 2003 |
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
Topics: Autoantigens; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Interleukin-6; Linear Models; Menopause; Middle Aged; Norethindrone; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2003 |
Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.
Topics: Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Sweden | 2004 |
The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
Topics: Administration, Oral; Adult; Anxiety; Contraceptives, Oral, Synthetic; Depression; Dizziness; Estradiol; Estrogen Replacement Therapy; Female; Headache; Heart Rate; Hot Flashes; Humans; Latin America; Lipids; Menopause; Middle Aged; Muscle Weakness; Norethindrone; Norethindrone Acetate; Paresthesia; Prospective Studies | 2005 |
The role of hormone replacement therapy in endometrial polyp formation.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis | 2005 |
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Testosterone | 2005 |
Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Case-Control Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; gamma-Glutamyltransferase; Humans; Linear Models; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Triglycerides | 2007 |
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
Topics: Adult; Aged; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hot Flashes; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Severity of Illness Index; Vagina | 2007 |
Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance.
Topics: Carotid Artery, Common; Double-Blind Method; Estradiol; Female; Homocysteine; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prospective Studies; Pulsatile Flow; Ultrasonography; Vascular Resistance | 2007 |
Progestogen-estrogen therapy in the menopause. A double blind study.
Topics: Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone | 1967 |
Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin').
Topics: 17-Ketosteroids; Castration; Equilin; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Postoperative Care; Time Factors; Uterine Neoplasms | 1980 |
Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Uric Acid | 1983 |
Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
Topics: Calcium; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Norethindrone; Osteoporosis | 1984 |
Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Clinical Trials as Topic; Estradiol; Estriol; Estrogens; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis | 1984 |
The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women.
Topics: Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Mental Disorders; Middle Aged; Norethindrone | 1984 |
Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Calcium-Binding Proteins; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin | 1984 |
Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
Topics: Calcium; Coronary Disease; Drug Therapy, Combination; Estradiol; Estriol; Female; Hormones; Humans; Menopause; Norethindrone; Osteoporosis; Risk | 1984 |
Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Topics: Adult; Cholesterol; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Placebos | 1984 |
Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.
Topics: Adult; Blood Pressure; Bone and Bones; Calcium; Cholesterol; Climacteric; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Random Allocation | 1982 |
Steroid and gonadotropin profiles in menopausal women on three different oral replacement regimens.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Norgestrel | 1980 |
Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis; Phosphates; Progestins | 1981 |
Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prolactin; Radioimmunoassay; Random Allocation; Time Factors | 1982 |
Combined estrogen and progestogen for the menopause.
Topics: Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Random Allocation | 1980 |
Changes in plasma renin concentration, activity and substrate after twentyeight days' treatment with micronized estrogen, ethinylestradiol and norethisterone-acetate in postmenopausal women.
Topics: Adult; Angiotensinogen; Angiotensins; Estrogens; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Radioimmunoassay; Renin | 1981 |
Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1981 |
Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Topics: Aged; Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Osteoporosis | 1982 |
[Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study].
Topics: Adult; Bendroflumethiazide; Coronary Disease; Double-Blind Method; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Placebos | 1981 |
Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Climate; Drug Eruptions; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 1994 |
Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study.
Topics: Activities of Daily Living; Adult; Aged; Arthritis, Rheumatoid; Bone Density; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Humans; Menopause; Middle Aged; Norethindrone; Radius; Spine | 1994 |
Oral versus transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Bone Density; Cardiovascular Diseases; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Lipoproteins; Longitudinal Studies; Menopause; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides; White People | 1993 |
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Topics: Administration, Oral; Climacteric; Desogestrel; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Physical Fitness; Placebos; Postmenopause; Progesterone Congeners; Sweating; Uterine Hemorrhage | 1996 |
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases | 1998 |
Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
Topics: Bone Density; Cross-Sectional Studies; Denmark; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal | 1999 |
Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy.
Topics: Administration, Cutaneous; Endometrial Hyperplasia; Estradiol; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Norethindrone; Sensitivity and Specificity; Ultrasonography | 1999 |
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1999 |
Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women.
Topics: Adult; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cross-Sectional Studies; Esterification; Estradiol; Estrogen Replacement Therapy; Female; Glycoproteins; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Postmenopause; Premenopause; Progesterone Congeners; Single-Blind Method | 1999 |
Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Topics: Administration, Cutaneous; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Progesterone Congeners; Sweating | 2000 |
Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Topics: Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Uterine Hemorrhage | 1998 |
Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.
Topics: Age Factors; Bone Density; Cross-Sectional Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis; Progesterone Congeners | 2002 |
Effect of raloxifene on the ovarian circulation in women after menopause.
Topics: Aged; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Ovary; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Single-Blind Method; Vascular Resistance | 2002 |
Effect of hormone replacement therapy on glucose tolerance in postmenopausal women.
Topics: Adult; Blood Glucose; Estradiol; Estrogens, Conjugated (USP); Ethynodiol Diacetate; Female; Glucose Tolerance Test; Humans; Megestrol; Menopause; Mestranol; Middle Aged; Norethindrone | 1977 |
The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Topics: Bone and Bones; Bone Regeneration; Bone Resorption; Calcium; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Intestinal Absorption; Menopause; Norethindrone; Osteoporosis; Surgery, Plastic | 1977 |
Menopausal therapy and endometrial pathology.
Topics: Drug Combinations; Endometrium; Estradiol; Female; Humans; Menopause; Norethindrone; Norgestrel | 1978 |
Bleeding patterns during continuous combined estrogen-progestogen therapy.
Topics: Amenorrhea; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hemorrhage; Humans; Menopause; Middle Aged; Norethindrone; Patient Compliance | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
Transdermal administration of oestrogen/progestagen hormone replacement therapy.
Topics: Administration, Cutaneous; Adult; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Surveys and Questionnaires | 1990 |
Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Bone Density; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Femur Head; Humans; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Topics: Bone Density; Calcium; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Long-Term Care; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 1990 |
Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones.
Topics: Aged; Anabolic Agents; Collagen; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Nandrolone; Nandrolone Decanoate; Norethindrone; Norethindrone Acetate; Peptide Fragments; Procollagen | 1990 |
The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
Topics: Administration, Cutaneous; Administration, Oral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Time Factors; United Kingdom | 1990 |
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors | 1989 |
A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy.
Topics: Adult; Aged; Analysis of Variance; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Megestrol; Menopause; Middle Aged; Norethindrone; Random Allocation; Uterine Hemorrhage | 1989 |
[Experience in the treatment of metastatic breast carcinoma with norethisterone acetate in a clinical study].
Topics: Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Menopause; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate; Remission Induction; Time Factors | 1989 |
Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Lipoproteins, VLDL; Megestrol; Menopause; Middle Aged; Norethindrone; Progestins; Random Allocation; Triglycerides | 1989 |
The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
Topics: Drug Combinations; Estradiol; Female; Glycodelin; Glycoproteins; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy Proteins; Radioimmunoassay; Random Allocation | 1989 |
Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
Topics: Bone Development; Bone Resorption; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Progestins | 1985 |
Benefits and risks of different hormonal replacement therapies in post-menopausal women.
Topics: Adult; Cholesterol; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Endometrium; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norpregnenes | 1986 |
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Topics: Alkaline Phosphatase; Biochemical Phenomena; Biochemistry; Bone and Bones; Calcium; Calcium-Binding Proteins; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteoporosis; Radionuclide Imaging; Random Allocation | 1988 |
Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Norethindrone | 1987 |
Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.
Topics: Adult; Antithrombin III; Dose-Response Relationship, Drug; Ethinyl Estradiol; Factor XII; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Partial Thromboplastin Time; Prospective Studies; Prothrombin; Random Allocation | 1988 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Hydroxyproline/creatinine ratios as estimates of bone resorption in early postmenopausal women. Fasting and 24-h urine samples compared.
Topics: Bone Resorption; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Menopause; Middle Aged; Norethindrone | 1986 |
The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
Topics: Adult; Climacteric; Double-Blind Method; Estradiol; Female; Humans; Menopause; Middle Aged; Models, Biological; Norethindrone; Premenstrual Syndrome; Prospective Studies; Testosterone | 1986 |
Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estrogens; Female; Hemorrhage; Humans; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Vaginal Diseases | 1987 |
Photon absorptiometry studies in osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Drug Combinations; Estradiol; Estriol; Female; Fluorides; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis; Radionuclide Imaging; Vitamin D | 1985 |
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Smoking | 1985 |
Prevention of bone mineral loss in postmenopausal women by norethisterone.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Drug Evaluation; Female; Humans; Hydroxyproline; Kidney Tubules; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis; Phosphates; Time Factors | 1985 |
[Treatment of hormonally induced bleeding abnormalities and psychovegetative disorders with a two-phase preparation].
Topics: Adolescent; Adult; Amenorrhea; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Menopause; Menstruation Disturbances; Middle Aged; Norethindrone | 1974 |
Graded sequential therapy in the menopause: a double-blind study.
Topics: Anxiety; Clinical Trials as Topic; Estrogens; Female; Fever; Genital Diseases, Female; Headache; Humans; Menopause; Mestranol; Middle Aged; Norethindrone; Placebos | 1971 |
143 other study(ies) available for norethindrone and Menopause
Article | Year |
---|---|
Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy.
Topics: Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norway; Prospective Studies; Quality of Life; Surveys and Questionnaires; Sweden; Treatment Outcome; Uterine Hemorrhage | 2015 |
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Topics: Administration, Cutaneous; Aspirin; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Female; Hemostasis; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Poland | 2015 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism | 2016 |
Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
Topics: Administration, Cutaneous; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Middle Aged; Norethindrone; Pilot Projects | 2008 |
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.
Topics: Adult; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Life Style; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Sweden; Women's Health | 2009 |
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone | 2011 |
Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptoms.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Quality-Adjusted Life Years | 2003 |
Norethisterone in the control of menopausal symptoms.
Topics: Female; Humans; Menopause; Norethindrone; Progesterone | 1962 |
OVULATION CONTROL.
Topics: Contraceptive Agents; Contraceptives, Oral; Estrogens; Female; Humans; Menopause; Menstruation; Mestranol; Norethindrone; Norethynodrel; Ovulation; Toxicology | 1963 |
PROGESTINS AND THE OVARY.
Topics: Aging; Animals; Contraceptive Agents; Contraceptives, Oral; Female; Geriatrics; Humans; Menopause; Norethindrone; Ovary; Pharmacology; Poultry; Pregnancy; Progestins; Research | 1964 |
NORETHINDRONE MESTRANOL AS A THERAPEUTIC AGENT.
Topics: Acne Vulgaris; Amenorrhea; Drug Therapy; Dysmenorrhea; Estrogens; Female; Gynecology; Humans; Infertility; Infertility, Female; Menopause; Mestranol; Metrorrhagia; Norethindrone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Premenstrual Syndrome; Psoriasis; Uterine Hemorrhage | 1964 |
MENOPAUSAL BLEEDING.
Topics: Diagnosis; Drug Therapy; Estrogens; Female; Humans; Menopause; Mestranol; Norethindrone; Surgical Procedures, Operative; Uterine Hemorrhage | 1964 |
[THERAPEUTIC INDICATION FOR OVULATION BY CYCLIC ADMINISTRATION OF ANOVLAR].
Topics: Drug Combinations; Drug Therapy; Dysmenorrhea; Endometriosis; Ethinyl Estradiol; Female; Humans; Infertility; Infertility, Female; Menopause; Menorrhagia; Metrorrhagia; Norethindrone; Ovulation | 1965 |
ORAL CONTRACEPTIVES AND LIVER DAMAGE.
Topics: Biopsy; Chemical and Drug Induced Liver Injury; Contraceptive Agents; Contraceptives, Oral; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Hepatitis; Humans; Liver Function Tests; Lynestrenol; Menopause; Mestranol; Norethindrone; Norethynodrel; Progestins; Toxicology | 1965 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS.
Topics: Chemical and Drug Induced Liver Injury; Contraceptive Agents; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Hepatitis; Humans; Liver Diseases; Liver Function Tests; Lynestrenol; Megestrol; Menopause; Mestranol; Norethindrone; Norethynodrel; Toxicology | 1965 |
Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests | 2003 |
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Polyps; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Retrospective Studies | 2004 |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Topics: Acetylcholine; Animals; Arteries; Calcium; Coronary Vessels; Disease Models, Animal; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Menopause; NG-Nitroarginine Methyl Ester; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Progestins; Rabbits; Vasoconstriction; Vasodilation | 2004 |
Treatment of the artificial menopause.
Topics: Barbiturates; Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Menopause; Middle Aged; Norethindrone; Trifluoperazine | 1967 |
Blood coagulation, fibrinolysis, and contraceptive hormones.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Estrogens; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Menopause; Mestranol; Middle Aged; Norethindrone; Plasminogen; Progesterone; Prothrombin Time; Sex | 1967 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Topics: Cholesterol; Drug Combinations; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Mestranol; Norethindrone; Norgestrel; Time Factors; Triglycerides | 1980 |
The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins.
Topics: 17-Hydroxysteroid Dehydrogenases; DNA; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Norethindrone; Norgestrel; Receptors, Estradiol; Receptors, Estrogen | 1981 |
Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy.
Topics: DNA; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners | 1982 |
Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium.
Topics: Cell Nucleus; DNA; Dose-Response Relationship, Drug; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Estradiol; Receptors, Estrogen | 1981 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
Sex hormones and skin collagen content in postmenopausal women.
Topics: Adult; Collagen; Estradiol; Female; Gonadal Steroid Hormones; Humans; Menopause; Middle Aged; Norethindrone; Skin; Testosterone | 1983 |
Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Topics: Adult; Climacteric; Double-Blind Method; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1984 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
On the mechanism of action of progestins.
Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen | 1981 |
Mechanism of action of contraceptive synthetic progestins.
Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep | 1981 |
A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
Topics: Adult; Climacteric; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1984 |
A double-blind trial of ethinyl oestradiol and norethisterone separately and together, in menopausal women.
Topics: Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone; Surveys and Questionnaires | 1983 |
A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Triglycerides | 1983 |
Effect on lipoproteins of Trisequens, a combined hormone preparation.
Topics: Adult; Castration; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Risk; Triglycerides | 1984 |
Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
Topics: Aged; Bone and Bones; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis | 1983 |
Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
Topics: Adult; Androstenedione; Climacteric; Estradiol; Estriol; Estrone; Female; Gonadotropins; Humans; Menopause; Middle Aged; Norethindrone; Sex Hormone-Binding Globulin; Testosterone | 1983 |
Compliance difficulties with progestin-supplemented estrogen replacement therapy.
Topics: Aged; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Patient Compliance | 1984 |
Hormone replacement treatment and benign intracranial hypertension.
Topics: Female; Humans; Menopause; Mestranol; Middle Aged; Norethindrone; Pseudotumor Cerebri | 1982 |
Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Topics: Bendroflumethiazide; Climacteric; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1982 |
Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract.
Topics: Cervix Uteri; Climacteric; Epithelium; Female; Humans; Menopause; Mestranol; Microscopy, Electron, Scanning; Middle Aged; Norethindrone; Urine; Vagina; Vaginal Smears | 1982 |
Effects of various types and dosages of progestogens on the postmenopausal endometrium.
Topics: DNA; Endometrium; Enzyme Induction; Estradiol Dehydrogenases; Estrogens; Female; Humans; Menopause; Mitosis; Norethindrone; Norgestrel; Progestins | 1982 |
Lipid and carbohydrate metabolism studies in oophorectomized women: effects produced by the addition of norethisterone acetate to two estrogen preparations.
Topics: Adult; Carbohydrate Metabolism; Castration; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Lipid Metabolism; Menopause; Metabolism; Middle Aged; Norethindrone | 1982 |
Psychophysiological stress responses in postmenopausal women before and after hormonal replacement therapy.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Estradiol; Estriol; Female; Heart Rate; Hormones; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Stress, Psychological; Sweating | 1982 |
The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles.
Topics: Adult; Alkaline Phosphatase; Blood; Calcium; Female; Humans; Menopause; Mestranol; Middle Aged; Norethindrone; Serum Albumin; Sodium; Urea | 1981 |
Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
Topics: Cell Nucleus; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; Menopause; Norethindrone; Receptors, Estrogen | 1981 |
Trisequens.
Topics: Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone | 1981 |
[The effect of norethisterone acetate and 17 alpha-cyanomethyl-estradiol-3-methyl ether on the serum lipid levels].
Topics: Aged; Cholesterol; Estradiol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Triglycerides | 1981 |
Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Blood Pressure; Body Weight; Coronary Disease; Double-Blind Method; Estrenes; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone | 1981 |
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; Isocitrate Dehydrogenase; Menopause; Norethindrone; Norgestrel; Piperazines; Progestins; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Treatment of spinal osteoporosis in postmenopausal women.
Topics: Aged; Calcium; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Norethindrone; Osteoporosis; Spinal Diseases; Vitamin D | 1980 |
Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Topics: Cholesterol; Drug Administration Schedule; Estradiol; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners | 1981 |
Hormone replacement therapy by the transdermal administration of oestradiol and norethisterone.
Topics: Administration, Cutaneous; Adult; Biopsy; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Flushing; Humans; Menopause; Middle Aged; Norethindrone; Prospective Studies; Sweating | 1994 |
Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
Topics: Administration, Cutaneous; Adult; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies | 1993 |
Endometrial responses to hormone replacement therapy: the bleeding pattern.
Topics: Adult; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Smoking; Time Factors | 1996 |
Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause.
Topics: 20-alpha-Dihydroprogesterone; Administration, Cutaneous; Blood Coagulation; Blood Pressure; Body Mass Index; Bone and Bones; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1996 |
Sonographic measurement of endometrial thickness as a predictor of vaginal bleeding in women using continuous combined hormone replacement therapy.
Topics: Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage | 1997 |
Research in progress.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Prevalence; Research | 1998 |
Endometrial cytology in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Cell Nucleus; Cytodiagnosis; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone | 1998 |
Cardiovascular responses of perimenopausal women to hormonal replacement therapy.
Topics: Blood Pressure; Cardiac Output; Cardiovascular System; Echocardiography; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Menopause; Middle Aged; Norethindrone; Stroke Volume; Vascular Capacitance | 2000 |
Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Feces; Female; Glucuronides; Haplorhini; Humans; In Vitro Techniques; Liver; Menopause; Middle Aged; Norethindrone; Progesterone Congeners; Rats; Species Specificity | 2000 |
Vitamin-D analogues and renal function.
Topics: Aged; Calcium; Creatinine; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Hypercalcemia; Kidney; Menopause; Middle Aged; Norethindrone; Osteoporosis; Uremia | 1978 |
Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
Topics: Adenocarcinoma; Administration, Oral; Aged; Climacteric; Endometrial Hyperplasia; Estradiol Congeners; Female; Humans; Menopause; Middle Aged; Norethindrone; Uterine Neoplasms | 1979 |
Use of hormones in women over forty.
Topics: Aged; Climacteric; Drug Administration Schedule; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Menopause; Middle Aged; Neurotic Disorders; Norethindrone; Vaginitis | 1977 |
An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
Topics: Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menopause; Mestranol; Norethindrone; Norgestrel; Pregnancy; Transcortin | 1978 |
Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
Topics: Cell Nucleus; Endometrium; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Female; Humans; Menopause; Norethindrone; Receptors, Estrogen; Receptors, Progesterone | 1978 |
The effects of cyclical oestrogen therapy and sequential oestrogen/progestogen therapy on the endometrium of postmenopausal women.
Topics: Endometrium; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Menopause; Norethindrone; Uterine Hemorrhage; Uterine Neoplasms; Vacuum Curettage | 1977 |
Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women.
Topics: Aged; Castration; Cholesterol; Drug Therapy, Combination; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Lipids; Menopause; Menopause, Premature; Middle Aged; Norethindrone; Phospholipids; Tablets; Triglycerides | 1979 |
The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
Topics: Adult; Body Weight; Cholesterol; Female; Humans; Lipoproteins; Menopause; Mestranol; Middle Aged; Norethindrone; Triglycerides | 1979 |
Treatment of advanced breast cancer with norethisterone acetate.
Topics: Age Factors; Aged; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate | 1979 |
A new and sensitive method for quantifying and comparing the biological potency of varius estrogens in man.
Topics: Contraceptives, Oral, Sequential; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Norethindrone; Pregnancy Proteins; Radioimmunoassay | 1979 |
Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Topics: Cholesterol; Climacteric; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Triglycerides | 1977 |
Scanning electron microscopy of the effect of short-term hormonal therapy on postmenopausal endometrium.
Topics: Aged; Endometrium; Epithelium; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Microscopy, Electron, Scanning; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Time Factors | 1978 |
Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
Topics: Bone and Bones; Climacteric; Drug Therapy, Combination; Estradiol; Estriol; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Minerals; Norethindrone | 1978 |
Effects of progestogens on serum lipids in the post-menopause.
Topics: Adult; Castration; Cholesterol; Climacteric; Estrogens; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Phospholipids; Triglycerides | 1978 |
Pregnancy associated alpha2-glycoprotein in post-menopausal women receiving hormone replacement therapy.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Glycoproteins; Humans; Menopause; Menstruation; Mestranol; Middle Aged; Norethindrone; Pregnancy; Time Factors | 1976 |
Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
Topics: Adult; Blood Proteins; Female; Humans; Menopause; Mestranol; Middle Aged; Norethindrone | 1976 |
The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and post-menopausal women, and its possible significance.
Topics: Adult; Cholesterol; Female; Follicle Stimulating Hormone; Humans; Lipids; Menopause; Mestranol; Middle Aged; Norethindrone; Triglycerides | 1976 |
Oral treatment of menopausal symptoms with natural oestrogens. Experiences with a new series of oestrogens and oestrogen-gestagen combinations.
Topics: Administration, Oral; Adult; Aged; Body Weight; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Time Factors | 1975 |
Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects.
Topics: Diethylstilbestrol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Megestrol; Menopause; Menstruation; Mestranol; Norethindrone; Ovulation; Pituitary Gland; Radioimmunoassay; Time Factors | 1975 |
Human cervical mucus during the menstrual cycle and pregnancy in normal and pathological conditions.
Topics: Cervix Mucus; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Menopause; Menstruation; Microscopy, Electron, Scanning; Norethindrone; Ovulation; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy Trimester, Third | 1975 |
The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
Topics: Clinical Protocols; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Prospective Studies | 1992 |
The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
Effect of 17 beta-oestradiol and norethisterone acetate on vertebral bone mass and lipid metabolism in early postmenopausal women.
Topics: Bone Density; Estradiol; Female; Humans; Lipids; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Progesterone Congeners; Prospective Studies | 1992 |
Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women.
Topics: Administration, Cutaneous; Affect; Attitude to Health; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Quality of Life | 1992 |
Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
Topics: Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Menopause; Norethindrone; Progesterone; Time Factors; Uterine Hemorrhage | 1991 |
Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.
Topics: Female; Humans; Lipoprotein(a); Lipoproteins; Menopause; Middle Aged; Norethindrone; Pilot Projects | 1991 |
[The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
Topics: Climacteric; Drug Combinations; Drug Evaluation; Estradiol; Estriol; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Uterine Hemorrhage | 1991 |
Oestrogens, arterial status, and postmenopausal women.
Topics: Arteries; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Uterus | 1990 |
Oestrogens, arterial status, and postmenopausal women.
Topics: Administration, Cutaneous; Arteries; Estradiol; Female; Humans; Menopause; Norethindrone; Uterus | 1990 |
Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids.
Topics: Adipose Tissue; Administration, Cutaneous; Administration, Oral; Blood Glucose; Blood Pressure; Body Weight; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Menopause; Middle Aged; Norethindrone; Progesterone; Sex Hormone-Binding Globulin; Triglycerides | 1990 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Changes in vitamin D metabolism during natural and medical menopause.
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Calcitriol; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Nafarelin; Norethindrone; Ovary; Pituitary Hormones; Seasons; Vitamin D; Vitamin D-Binding Protein | 1990 |
Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
Topics: Animals; Bone and Bones; Calcium; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrus; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteogenesis; Time Factors | 1990 |
Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
Topics: Adult; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy Proteins; Progesterone | 1990 |
In vivo conversion of norethisterone to ethynyloestradiol in perimenopausal women.
Topics: Biotransformation; Breast Neoplasms; Carbon Radioisotopes; Ethinyl Estradiol; Female; Humans; Menopause; Norethindrone | 1990 |
Treatment of postmenopausal hyperparathyroidism with norethindrone. Long-term effects on forearm mineral content.
Topics: Absorptiometry, Photon; Bone Density; Female; Humans; Hyperparathyroidism; Menopause; Middle Aged; Norethindrone; Radionuclide Imaging; Radius; Time Factors; Ulna | 1990 |
Cyclic therapy resulted in pregnancy in premature ovarian failure.
Topics: Adult; Chlormadinone Acetate; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menopause, Premature; Norethindrone; Norethindrone Acetate; Pregnancy | 1985 |
Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy.
Topics: Adult; Amenorrhea; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menopause; Menopause, Premature; Menotropins; Norethindrone; Pregnancy | 1989 |
The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.
Topics: Acid Phosphatase; Adult; Bone Resorption; Drug Resistance; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Ovariectomy; Tartrates | 1989 |
Prolactin levels in menopausal women on long-term estrogen implants.
Topics: Adult; Drug Implants; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menopause, Premature; Middle Aged; Norethindrone; Prolactin | 1989 |
[Neuroendocrinologic study of depressive disorders--with special reference to gonadal functions].
Topics: Aged; Climacteric; Depressive Disorder; Estradiol; Female; Fluoxymesterone; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menopause; Mestranol; Middle Aged; Norethindrone; Prolactin | 1989 |
Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy.
Topics: Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins; Menopause; Norethindrone; Random Allocation | 1989 |
[Single-hormone prophylaxis of uterine hemorrhages in the premenopause].
Topics: Climacteric; Drug Evaluation; Female; Humans; Menopause; Menopause, Premature; Menstrual Cycle; Middle Aged; Norethindrone; Norsteroids; Uterine Hemorrhage | 1989 |
Are fixed-dose oestrogen/progestogen combinations ideal for all HRT users?
Topics: Cell Division; Drug Therapy, Combination; Endometrium; Estrogens; Female; Humans; Menopause; Norethindrone; Norgestrel; Retrospective Studies | 1989 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
[Changes in plasma binding protein of sex steroids and transcortin during the treatment of menopause with oral estrogens].
Topics: Administration, Oral; Estradiol; Estrogens; Estrone; Female; Gonadotropins; Humans; Menopause; Middle Aged; Norethindrone; Pregnancy; Sex Hormone-Binding Globulin; Transcortin | 1988 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
Topics: Administration, Oral; Aged; Amenorrhea; Atrophy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone | 1985 |
Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.
Topics: Adult; Aged; Climacteric; Estradiol; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Naloxone; Norethindrone; Ovariectomy; Receptors, Opioid | 1985 |
Amenorrhea and endometrial atrophy.
Topics: Amenorrhea; Atrophy; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Lipids; Menopause; Norethindrone; Thrombophlebitis | 1985 |
Sex steroid replacement in post-menopausal women: effects on thyroid hormone status.
Topics: Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norgestrel; Thyroid Hormones | 1987 |
Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women.
Topics: Adult; Drug Combinations; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Menopause; Middle Aged; Norethindrone; Ovariectomy; Progestins; Sex Hormone-Binding Globulin | 1988 |
Changes in the bone and liver isoenzymes of alkaline phosphatase in postmenopausal women being treated with norethisterone.
Topics: Alkaline Phosphatase; Bone and Bones; Female; Humans; Isoenzymes; Liver; Menopause; Middle Aged; Norethindrone | 1988 |
Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus; Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Triglycerides | 1986 |
Use of progestogen therapy.
Topics: Breast Neoplasms; Cholesterol, HDL; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Risk; Uterine Neoplasms | 1987 |
Norethisterone in postmenopausal osteoporosis.
Topics: Calcium; Female; Humans; Menopause; Norethindrone; Osteoporosis | 1987 |
Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1986 |
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
Topics: Bone Resorption; Calcitriol; Calcium; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Hyperparathyroidism; Menopause; Middle Aged; Norethindrone; Parathyroid Hormone; Time Factors; Vitamin D-Binding Protein | 1986 |
Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norethindrone | 1986 |
The influence of short-term estrogen replacement therapy (ERT) on the blood pressure and daily urinary catecholamine excretion in a small group of post-menopausal women.
Topics: Blood Pressure; Catecholamines; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone | 1986 |
Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Topics: Aged; Bone and Bones; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidism; Menopause; Middle Aged; Minerals; Norethindrone; Parathyroid Hormone; Phosphates | 1987 |
Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
Topics: Atrophy; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Topics: Adult; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.
Topics: Bone Resorption; Calcitonin; Calcitriol; Calcium; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged; Norethindrone; Parathyroid Hormone; Vitamin D-Binding Protein | 1985 |
Endometrial responses to transdermal estradiol in postmenopausal women.
Topics: Administration, Topical; Adult; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Skin; Uterine Hemorrhage | 1985 |
Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy.
Topics: Abdomen, Acute; Aged; Climacteric; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Uterine Hemorrhage | 1985 |
Effects of oral ethinyl oestradiol and norethisterone on plasma copper and zinc complexes in post-menopausal women.
Topics: Administration, Oral; Blood Proteins; Copper; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Protein Binding; Serum Albumin; Zinc | 1985 |
Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
Topics: Administration, Oral; Adult; Drug Implants; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Testosterone | 1985 |
[Urinary gonadotropin in gynecology with special reference to adrenocortical function].
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Animals; Castration; Clomiphene; Dexamethasone; Female; Gonadotropins, Pituitary; Humans; Menopause; Menstruation; Mestranol; Mice; Middle Aged; Norethindrone; Prednisolone; Stilbenes; Triiodothyronine | 1966 |
Measurement of human luteinizing hormone in plasma by radioimmunoassay.
Topics: Acromegaly; Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Animals; Biological Assay; Chorionic Gonadotropin; Disease; Estrogens; Female; Feminization; Follicle Stimulating Hormone; Gonads; Guinea Pigs; Humans; Immune Sera; Iodine Isotopes; Kinetics; Luteinizing Hormone; Male; Menopause; Menstruation; Mestranol; Middle Aged; Norethindrone; Pituitary Diseases; Pituitary Gland; Puberty; Radioimmunoassay; Testosterone; Thyroid Diseases; Thyrotropin | 1968 |
The climacteric.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone | 1973 |
Massive hyperlipemia during estrogen therapy.
Topics: Acetates; Adult; Cholesterol; Contraceptives, Oral; Dose-Response Relationship, Drug; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hyperlipidemias; Hypertension; Menopause; Mestranol; Middle Aged; Norethindrone; Triglycerides | 1974 |
[Results of norethindrone (norluten) treatment of diffusion phase breast cancer].
Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Norethindrone; Time Factors | 1968 |
Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference.
Topics: Administration, Oral; Dosage Forms; Drug Tolerance; Estradiol; Female; Humans; Menopause; Mestranol; Norethindrone; Time Factors | 1972 |
The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.
Topics: Adult; Age Factors; Carboxy-Lyases; Carcinogens; Contraceptives, Oral; Ethinyl Estradiol; Female; Glucuronates; Hippurates; Humans; Kynurenic Acid; Kynurenine; Male; Menopause; Menstruation; Middle Aged; Norethindrone; ortho-Aminobenzoates; Ovulation; Pyridoxine; Sex Factors; Tryptophan; Xanthurenates | 1970 |
Suppressive action of norethisterone enanthate and acetate on gonadotropin. (FSH and LH) levels. Radioimmunoassay in eugonadal and postmenopausal women.
Topics: Acetates; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Norethindrone; Radioimmunoassay | 1970 |
[Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].
Topics: Acetates; Adult; Castration; Circadian Rhythm; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menopause; Menstruation; Mestranol; Middle Aged; Norethindrone; Norgestrel; Time Factors | 1970 |
[Gonadotropin secretion in man].
Topics: Adolescent; Adult; Clomiphene; Contraceptives, Oral; Estradiol; Female; Follicle Stimulating Hormone; Humans; Klinefelter Syndrome; Luteinizing Hormone; Male; Menopause; Menstruation; Norethindrone; Ovulation; Progesterone; Radioimmunoassay; Testosterone | 1970 |
Management of abnormal bleeding.
Topics: Aminocaproates; Contraceptives, Oral; Curettage; Estrogens; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Hemorrhage; Humans; Hysterectomy; Menopause; Menorrhagia; Mestranol; Norethindrone; Progestins; Uterine Hemorrhage | 1971 |